Novo Nordisk's pricing approaches inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of selling price gouging, stating the stark distinction concerning U.S. rates and people in Europe and copyright.are scheduled to own operation or other strategies that use anesthesia or deep sleepiness